spironolactone has been researched along with physostigmine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lerer, B | 1 |
Selye, H | 1 |
Poppe, W; Stöber, G | 1 |
FARDEAU, M | 1 |
BOUDIN, G; GOULON, M; HAMBURGER, J; LAPRESLE, J; LHERMITTE, F; PEQUIGNOT, H | 1 |
2 review(s) available for spironolactone and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
10 other study(ies) available for spironolactone and physostigmine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Resistance to various pesticides induced by catatoxic steroids.
Topics: Administration, Oral; Anabolic Agents; Animals; DDT; Desoxycorticosterone; Estradiol; Ethylestrenol; Female; Insecticides; Oxandrolone; Parathion; Phosphoric Acids; Physostigmine; Pralidoxime Compounds; Prednisolone; Pregnanediol; Pregnanes; Progesterone; Rats; Spironolactone; Steroids; Thyroxine; Triamcinolone | 1970 |
[On the diagnosis and therapy of myasthenia gravis pseudoparalytica].
Topics: Diagnosis, Differential; Female; Humans; Middle Aged; Myasthenia Gravis; Physostigmine; Spironolactone | 1969 |
[MYASTHENIA].
Topics: Ammonium Compounds; Blood; Cardiovascular Agents; Child; Diagnosis; Endocrinology; Ephedrine; Guanidines; Humans; Muscle Relaxants, Central; Myasthenia Gravis; Neostigmine; Pathology; Physostigmine; Quaternary Ammonium Compounds; Respiratory Insufficiency; Spironolactone; Thymus Gland | 1964 |
[HOW TO TREAT MYASTHENIA].
Topics: Ambenonium Chloride; Ephedrine; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Physostigmine; Prognosis; Pyridostigmine Bromide; Respiratory Insufficiency; Spironolactone; Surgical Procedures, Operative; Thymus Neoplasms | 1964 |